Uncategorized Wedbush Raises Oklo Inc. (OKLO)’s Price Target to $55, Maintains Outperform Rating Post Content
Uncategorized Option traders moderately bearish in Advanced Micro Devices with shares down 1.59% Post Content
Uncategorized Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost Post Content
Uncategorized GSK plc (GSK) Stock Rises as FDA Approves Nucala for COPD, CHMP Backs Blenrep for Cancer Treatment Post Content
Uncategorized Palantir Technologies Inc. (PLTR) CEO Sells $50M in Shares as Execs Also Cut Holdings Post Content
Uncategorized Gilead Sciences, Inc. (GILD)’s Breast Cancer Study Success Drives Investor Optimism Amid Broader Market Slump Post Content